---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-013498"
form_type: "8-K"
ticker: "OSRH"
cik: "0001840425"
company_name: "OSR Holdings, Inc."
filed_at: "2025-02-13T23:59:59+00:00"
generated_at: "2026-05-26T22:23:54.170204+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# BLAC stockholders approve business combination with OSR Holdings; name change to OSR Holdings, Inc.

## Summary
- All proposals approved at Feb 13 special meeting; 93.95% quorum; 57,821 shares redeemed.
- Transaction expected to close Feb 14 after foreign investment approval from Industrial Bank of Korea.
- Post-close, OSR Holdings will own ~67% of OSR; additional 22% subject to put/call from 2026.
- New tickers OSRH (common) and OSRHW (warrants) begin trading on Nasdaq Feb 18.
- Nine directors elected; portfolio includes Phase 2 immunotherapy, age-related therapies, medical device distribution.

## SEC filing metadata
- accession: 0001213900-25-013498
- form_type: 8-K
- ticker: OSRH
- cik: 0001840425
- company_name: OSR Holdings, Inc.
- filed_at: 2025-02-13T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 5.03, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840425/000121390025013498/0001213900-25-013498-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840425/000121390025013498/ea0230563-8k425_bellevue.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-013498
- JSON: https://secwatch.observer/filing/0001213900-25-013498.json
- Plain text: https://secwatch.observer/filing/0001213900-25-013498.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.